Biotech Press Releases

Home - Industries - Biotech Press Releases - Archived Page 3

Biotech Press Releases (Archived Page 3)

  • AnaSpec Announces a Broad Selection of T-Cell Epitopes
  • Breath of Life Product In-Licensed to Samaritan Pharma
  • CEVEC again successful in challenge to Crucell patent
  • ARTES and Minapharm sign long-term strategic development agreement
  • AnaSpec Introduces New FRET Technology Brochure
  • Trevigen Launches Cultrex BME PathClear
  • Axium Awarded Phase III Clinical Trial Management Contract for OxThera`s Oxabact(tm)
  • AXIUM HEALTHCARE PHARMACY AWARDED PHASE III CLINICAL TRIAL MANAGEMENT CONTRACT FOR OXTHERA`S OXABACT(tm)
  • InfoStrength Launches New Life Science Website
  • AnaSpec Introduces Ten New Catalog Peptides
  • RNCOS Releases Report on Global Biometric Market
  • Premier Cord Blood Bank, LifebankUSATM, Reminds Clients to Take Advantage of their Exclusive, Limited-Time Holiday Offer
  • Evangelia Evdaimon starts third term with NCCSQA
  • AnaSpec Introduces First Colorimetric SensoLyte(tm) MMP Assay Kit
  • Anavex strengthens Board of Directors
  • RNCOS releases Report on Asia Pacific Biotechnology Market
  • ANAVEX advances drug candidates for treatment of epilepsy
  • ANAVEX 7-1037 demonstrates chemotherapeutic potential without toxic side effects for the treatment of colorectal cancer, other types of solid tumors
  • AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
  • InfoStrength and Clients enjoy win-win Relationship!
  • AnaSpec Introduces 10 New Catalog Antibodies
  • JT EATON INTRODUCES NEW SPRAY TO PREVENT TRANSPORT OF `UNWANTED GUESTS` IN LUGGAGE
  • AnaSpec Releases New Antibodies Brochure
  • Gain Back Lost Human Growth Hormone with GenF20(tm)HGH
  • GenF20(tm) HGH Pure Human Growth Hormone Releaser `Best Overall Health Tonic and Rejuvenator EVER`!
  • Biotechgate and Naturejobs Collaboration to Aid Recruiters and Jobseekers Globally
  • AnaSpec Introduces New Collection of Bcl Peptides
  • AnaSpec Introduces 17 New Anti-Tau Antibodies
  • PREMIER Biosoft International joins Microsoft in the BioIT Alliance
  • AnaSpec Celebrates the Holidays with Its Customers
  • AnaSpec Introduces AnaTag(tm) Protein Labeling Kits with HiLytePlus(tm)
  • GVK BIO raises Rs100 crores from Sequoia Capital
  • BioInformant launches Digital Protection Services to protect website content and ensure competitors are not using trademarks, products or brand names to misdirect online business
  • Laser Guidance Takes a Quantum Leap
  • ZYTO Corporation Announces Engagement of RedChip Companies to Lead Investor Relations
  • Los Angeles Health and Wellness Clinic Uses Biotechnology to Make Alternative Health Care Decisions
  • Cotati Alternative Health Care Professional Uses Biotechnology to Make Health Care Decisions
  • Lexington Chiropractor Uses `Star Trek` Technology for Alternative Health Care and Wellness
  • Madill Chiropractor Announces Addition of ZYTO Biotechnology to Improve Health Care Services
  • Mesa Naturopathic Physician Uses Biotechnology to Make Alternative Health Care Decisions
  • AnaSpec introduces HiLytePlus(tm) Labeled Secondary Antibodies and Streptavidin
  • DRE Announces Launch of Enhanced Medical Equipment Website
  • BioInformant Partners with Research Product Companies to Target Prospects with Responsive Email Lists
  • BioInformant Launches Product Citation Tracking and Database Management for Research Product Companies
  • AnaSpec Introduces Thirteen New Catalog Peptides
  • AnaSpec Introduces HiLytePlus(tm) - AnaSpec`s Highest Performance Fluorescent Dyes
  • Eufaula Naturopathic Doctor Uses Biotechnology to Make Alternative Health Care Decisions
  • Riverside Private Health Spa Uses Biotechnology to Make Alternative Health Care Decisions
  • Alexandria Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Farmington Health Care Clinic Uses Biotechnology to Make Alternative Health Care Decisions
  • Sapulpa Chiropractor Alternative Health Pain Clinic Uses Star Trek Technology for Health and Wellness
  • American Fork Chiropractor Uses Biotechnology to Decide on Alternative Health Care Solutions
  • South Surrey Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • SciMercor,LLC Launches as Scientific Equipment Sourcing Service - Specializing in Overseas Facilities
  • Transinsight wins futureSAX VC-Forum for best company
  • Clinical trials in computer
  • First Indian vaccine manufacturer to successfully produce Revac-Bmcf, a thimerosal-free Hepatitis B Vaccine
  • Bioinformatics Institute of India introduces an Informative Directory of Clinical Trials
  • Bioinformatics - New Potion for Biotech and Pharma Firms, says RNCOS
  • InfoStrength(r) Hires James Comito Software Developer
  • Sector Close Up - Pharmaceutical and Biotech Stocks - Is Gene Therapy the Next Major Breakthrough in Cancer Treatment
  • The DANI MASTER Gas Chromatograph will speed up your productivity and improve your precision
  • BioMinds LifeSciences announces the release of PathoOligoDB(TM), a free data bank of validated qPCR oligos and related resources for pathogen detection
  • The US biotech market has been experiencing diverse changes for the past few years, but despite these changes, it is only booming
  • High tech `Bond` style technology reaches Dorset homes
  • FEECO International to Exhibit at the 2007 International Distillers Grain Conference
  • Indian Biotechnology Market Outlook (2006)
  • Dr David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to give Keynote presentation at 3rd Modern Drug Discovery and Development Summit
  • AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging
  • AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides
  • Medical Device company uses InfoStrength for due diligence
  • METABOLIC DISEASE HAS A GREATER EFFECT ON THE HEALTH OF OUR SOCIETY THAN CANCER
  • GTCbio`s 5th International Conference on Vaccines - All Things Considered
  • The New Avegene ePipette Electronic Pipettor Family
  • AnaSpec Launches New SensoLyteTM Caspase-8 Assay Kit
  • SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery and Development Summit
  • AnaSpec Introduces Improved Website Search Tool
  • AnaSpec Introduces Anti-Keratin-18 and 19 Antibodies
  • AnaSpec Introduces Fifteen New Catalog Peptides
  • South Surrey Kinesiologist Adds Bio-technology to Improve Alternative Healthcare Services
  • Wilmington Chiropractor Adds ZYTO Biotechnology to Improve Patient Services
  • Hamilton Square Acupuncturist Uses Star Trek Technology for Health and Wellness
  • Fort Collins Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Eaton Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Denver Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • AnaSpec Introduces Series of Dye-Labeled Amino Acids and Resins
  • FEECO International Featured in US Industry Today Magazine
  • Brookfield Alternative Healthcare Announces Free Demo of ZYTO Technology
  • Columbia Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Sapulpa Chiropractor Adds ZYTO Biotechnology to Improve Health and Wellness Services
  • Los Angeles Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Kalispell Chiropractor Adds ZYTO Biotechnology to Improve Patient Services
  • Cotati Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • El Dorado Hills Chiropractor Adds ZYTO Biotechnology to Improve Chiropractic Healthcare
  • Creative Technology Services Joins Forces with CJPS Enterprises
  • AnaSpec Introduces Nine New Catalog Antibodies
  • ZYTO Corp Provides Biotechnology to Health and Nutrition Business in China
  • DNA Solutions
  • Definiens Receives Frost and Sullivan Award for Technology Leadership in the High Content Screening Market
  • DNA key to save Cambodian elephants
  • AnaSpec Introduces Thirty-Two New Catalog Peptides
  • PREMIER Biosoft International announces the release of a free edition of Beacon Designer
  • Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4(tm) Compounds
  • AnaSpec Introduces Fifty-Five New Catalog Peptides
  • AnaSpec`s Published References Passes 500
  • AnaSpec Introduces 10 New Catalog Antibodies
  • AnaSpec Introduces Industry`s Longest Wavelength Assay Kit for TACE Detection
  • AnaSpec Introduces CEF Control Peptide Pool
  • AnaSpec Introduces 28 New Catalog Antibodies
  • AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
  • New Non-Contact Microarrayer Replaces Pen Spotting
  • BiotechCrossing Offers an Exclusive Free 30-Day Trial Subscription
  • Live Blood Labs Microscopes provide the most innovative blood analysis methods for better blood analysis
  • Forensic Microscopes provide the best tools in forensic analysis, comparison, and detection
  • Projection microscopes com brings projection microscope technology to the field of study
  • Teaching Microscopes com answers all microscopy needs in the field of teaching
  • Microscopes from Tissue Culture Microscopescom produce the clearest, most detailed images to be studied in the field of living tissue research
  • Low Power Microscopes showcases the biggest array of stereo microscopes ever to be sold online
  • Microscopic images now seen in better and clarity and greater detail through Phase Contrast microscopy
  • Ore Microscopes brings microscopy equipment to provide the best tools for precision measurement and analysis of rocks and minerals
  • Toolmakers Microscopes announces the solution to microscopic measuring needs and minute detail analysis
  • PREMIER Biosoft Releases Version 5 of AlleleID with MLPA support
  • USB Microscopes launches USB Microscopes com, the best source of quality microscopes with USB connectivity
  • ENT Microscopes com provides the best quality microscopes for medical and dental surgery applications
  • Epi-Flourescence Microscopes is now the ultimate source for all fluorescence microscopy needs
  • Metallurgical Microscopes announces its website is the one-stop shop for all metallographic and epi-illumination microscopy needs
  • Polarizing Microscopes com offers better images through Cross Polarization lighting system
  • PREMIER Biosoft Releases Version 7 of Beacon Designer with Support for Scorpions(r) assays
  • Adult stem cells better choice than death or transplant for heart failure patients
  • Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
  • AnaSpec Introduces Acetylated and Methylated Lysines
  • Adult stem cells take New York woman from death`s door to dance floor
  • AnaSpec Introduces Fourteen New Catalog Peptides
  • AnaSpec Introduces 12 New Catalog Antibodies
  • 114 Blockbuster Drugs Accounted for 2006 Sales of US$ 233,7 bln
  • AnaSpec Introduces Ten New Catalog Peptides
  • India`s Biotechnology Industry Blooming
  • Definiens Reveals an Integrated Data Management Approach For Image Analysis in Life Sciences Enterprises
  • AnaSpec Introduces New Selection of Cathelicidin Peptides
  • AnaSpec Introduces Anti-MMP-1 and Anti-MMP-13 (Hinge) Antibodies
  • Biotech leader lifts lid on $100 billion stem cell scam
  • American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
  • AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
  • India - Biotech Industry Hit US$ 2 Billion Mark in 2006-07
  • Biodiesel Production Equipment
  • Aesis Research Group debuts the Life Sciences Business and Investment Daily featuring incisive commentary by thought leader Dr Ogan Gurel and others
  • Biotechnology - Planet`s Next Big Opportunity
  • AnaSpec Introduces New Anti-MOG (35-55) Antibody
  • PharmaChem Publishes AnaSpec Article on Peptides as Antigens
  • OSI Pharmaceuticals to Present on Enabling Technologies for Oncology Biomarker Discovery at GTCbio`s Rediscovering Biomarkers Detection, Development and Validation Conference (July 23-24, 2007, San Diego, CA)
  • AnaSpec Introduces New SensoLyte(tm) Beta-Secretase Assay Kit
  • BioAnalyte supports FDA Intact Protein Expression (IPEx) Mass Spectrometry Approaches for Label-free Relative Quantitation and Biomarker Discovery
  • AnaSpec Introduces Industry`s First and Only Anti-MOG ELISA Kits
  • Biosyn Press Releases
  • Human LDH Isoenzymes Available from Lee Biosolutions
  • E coli, salmonella, mold, mildew, staph virus virtually eliminated by Lumilife Systems(tm)
  • AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
  • Veeda Clinical Research Strengthens its Global Operations to Work as Single Global Brand
  • ENLASO (translate com) Creates Dedicated `Into-English` Translation and Localization Department
  • The imminent change of the antithrombotics market
  • Biotechnology Stock News - Natural Anti Inflammatory Biotechnology Pharmaceuticals Developer Acquires Marketing Company And Multiple Proprietary Technologies
  • Novel Agent for Reactive Metabolite Detection
  • Brothers jump out of the hearse and onto the golf course thanks to adult stem cells
  • Bio-Pharmaceuticals Driving Pharma and Biotech Sectors in India
  • AnaSpec Introduces Line of Insulin Receptor Antibodies
  • AnaSpec Introduces Thirteen New Catalog Peptides
  • DENOVA Royal Hydra Balance SQ9 DENOVA presents its new 2007 line Royal Hydra Balance SQ9 for dry and oily skin!
  • C-Reactive Protein Available to Researchers from Lee Biosolutions
  • FEECO International Releases Innovative Ethanol Site
  • Industry`s First West Nile Virus Protease Assay Kits
  • ZYTO Corp Annual Meeting of Stockholders Elects Board of Directors Following Biotechnology Conference
  • US Biotechnology Firms Grew Exponentially in 2006
  • Virginia Based Software Development Company Sponsors Annual Triangle Event
  • First Commercially Available Beta-Amyloid Peptides (1-44 to 1-48)
  • Human Hemoglobin now Available to Researchers from Lee Biosolutions
  • ENLASO (translate com) to Host Webinar on Taking Life Science Products to the International Market
  • Fortitech Mexico Announces Strategic Business Relocation
  • The Van Andel Research Institute and Emiliem Sign Major Translational Medicine and Biomarker Agreement
  • Malaysia Endeavors to Outsource Biotech Services from US
  • Beyond biogenerics - the real threats for therapeutic proteins
  • Protein Kinases Catalyze Phosphorylation of Other Proteins
  • Venture Valuation and BIOTECanada launch new online database of Canadian life sciences companies (www canadianlifesciences com)
  • Synamatix Announces Release of Bioinformatics Solutions for Second Generation Sequencers
  • GTCbio Announces 2007 Fellowship Awards and Charitable Donation
  • Human Alpha-1 Antitrypsin Antigen now Available to Researchers from Lee Biosolutions
  • Stem Cell Study - Future of Cardiovascular Research
  • Zyto Corp Announces Additional Presenter at Biotechnology Conference for Healthcare Practitioners
  • Interleukin and Chemokine Antibodies - Two Types of Cytokine Antibodies
  • AnaSpec Introduces 69 New Antibodies
  • ABRF Poster Presents Comparison of Fluorescent Peptide Synthesis Methods
  • Soaring Demand for Ethanol Spikes Corn Prices in US
  • Simplified TCR clonality assay kits for vaccine development and immunology research
  • Salivary Amylase Enzyme EC NO 3 2 1 1 from Human Saliva now Available to Researchers from Lee Biosolutions
  • AnaSpec Introduces 51 New Apoptosis-Related Antibodies
  • New Dye Solution for Far Red to NIR Imaging
  • Indian Stem Cell Market to Hit US$ 540 Million by 2010
  • Zyto Corp Announces Annual Conference for Healthcare Practitioners
  • Low Price DNA Polymerase AmpSure Taq from WISBiomed
  • D-dimer Antigen now Available to Researchers from Lee Biosolutions
  • AnaSpec Introduces AnaTag(tm) Protein Labeling Kits
  • AnaSpec Launches Optimized Website
  • India Leads Asian Biotech Sector
  • CTL Announces Validation of Reference Samples for use in Regulated Human, Pig, and Mouse ELISPOT Assays
  • Multi-Platform Technology Provides Ideal Base for Labeled Secondary Antibodies
  • High-Performance Spacer for Peptide Labeling
  • AnaSpec Introduces 82 New Antibodies
  • Rising Ethanol Demand can push Food Prices Higher
  • Very Low Density Lipoprotein (VLDL) Available to Researchers from Lee Biosolutions
  • Bio3 Research Srl, Milan -Italy,has been granted by the Australian Patent Office in the field of cardiovascular diseases related to HMGB1 over-expression and for the use of HMGB1 protein in connective tissue regeneration
  • Name Change - AnaSpec`s EnzoLyte is now SensoLyte(tm)
  • BioLED Lab on a Chip Technology Successfully Demonstrated
  • New Additions to AnaSpec`s SensoLyte(tm) MMP Product Line
  • TCRexpress Clone Screening Kit For T cell clone available from WISBiomed
  • Creabilis therapeutics SpA appoints Domenico Criscuolo as Chief Medical Officer
  • The new class of dipeptidyl peptidase IV (DPP-IV) inhibitors has one clear leader and many followers
  • Teen Author, Asad Moten, Aims to Provide the Answer to Several Medical Mysteries
  • TOP Classes of Biologics with 2006 Sales of US$ 63 8 bln
  • Automated internal perfusion with the Port-a-Patch
  • AnaSpec Makes In-House Fmoc and Boc Amino Acids Available to Public
  • VeriTask Software demonstrates Biometric Employee Time Clock(tm) at Texas Association of Staffing trade show
  • PREMIER Biosoft and PamGene International BV form an alliance
  • Genfit extends its drug discovery strategic alliances with Sanofi-Aventis and Solvay
  • Novexin`s sales boosted by InstantBlue gel stain
  • The market of recombinant coagulation factors is growing with next generation products
  • Small Businesses Get A New Release From The Audio Book Guide With `The E Myth Revisited` by Michael E Gerber
  • AnaSpec Introduces One of the World`s First Collections of Synthetic Phytochelatin Peptides
  • AnaSpec Introduces Fifty-Five New Catalog Peptides
  • Nestle licenses Novel Heart Disease product to Cambridge Theranostics
  • Overview On 2006 Sales Of TOP 20 Biologics To
  • Aurigene and Merck Serono enter a Discovery Collaboration to identify therapeutics for Autoimmune Disorders
  • Aurigene and Forest Laboratories to collaborate on Development of Novel Oral Therapeutics for Obesity and Metabolic Disorders
  • AnaSpec Makes In-House Line of Peptide Synthesis Accessories Available to Public
  • BioAsk offers Research Intelligence and Trend Analysis for free!
  • AnaSpec Key Supplier for Significant Study on pGlu Modified Beta-Amyloid Peptides
  • Expert Panel to Discuss the Progress of Project Bioshield
  • PREMIER Biosoft International Releases TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis
  • AnaSpec Introduces Suite of Rigorously Validated SOCS Antibodies
  • The right balance drives the field of PPAR agonist RandD
  • Biotech leader lashes media `lies` about stem cells
  • Odds favor Hawaiian`s return to health with stem cell therapy
  • Death sentence for Australian commuted by stem cells
  • `BioAsia 2007 Thailand` expects to attract over 15,000 visitors worldwide
  • Finnzymes Instruments releases a new line of PCR thermal cyclers and ultra-thin wall plastics
  • AnaSpec to Sell Classic Fluorescence Textbook
  • ASCB Poster Presents Immunocapture Techniques for Improved MMP Assay
  • Fluorinated Building Blocks Produce Molecules with Enhanced Physiological Activities
  • AnaSpec Introduces Line of Assay Kits for Phosphatase Detection
  • Ghrelin and Obestatin Peptides Linked to Appetite
  • SHANTHA - MERIEUX ALLIANCE TO INVEST IN STATE OF THE ART SUITE FOR ADVANCED VACCINE PRODUCTION
  • AgroMicron Adds Environmental Trade Division
  • Website reports on `super-secret` bionics industry
  • Published References to AnaSpec Products Surpasses 400
  • Earth Alive Resources Introduces All-Natural RapidAll Cleaning Solution
  • Thailand PM to open international symposium in Bangkok on stem cell therapy for the failing heart
  • TheraVitae Presents Positive Stem Cell Trial Results at American Heart Association Convention
  • Melanoma Epitopes Used in Studying Tumor Regression
  • ErbB2 (Her-2) and p53 - Important Antibodies for Cancer Research
  • Drug Delivery Research Leads to Non-invasive Treatments for Major Diseases
  • TRACON PHARMACEUTICALS, INC ANNOUNCES PRESENTATION AT RODMAN and RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE
  • BioAsia 2007 to Take Off in Thailand in November 2007
  • AnaSpec Introduces Improved MMP Detection Solutions
  • AnaSpec Introduces `Search by Research Topic` Functionality
  • PREMIER Biosoft and MRC-Holland form an alliance
  • Gentris Corporation Announces FDA 510(k) Submission for GentriSure Human Genomic DNA Reference Controls for CYP2D6 Gene
  • AnaSpec Expands Facilities for Antibodies and Assay Kits
  • Coelenterazine and Its Analogs Provide Major Advantages for Luminescent Calcium Detection
  • BiotechIndustryStocks com - Biotechnology Investor Portal Updates and Expands Directory of Biotechnology Stocks
  • Homo-Amino Acids Provide Novel Options for Drug Discovery
  • PREMIER Biosoft International Releases SimGlycan, An Innovative Glycan Mass Fingerprinting Tool
  • US Ethanol Production and Demand reach all time Highs
  • GenoSensor Signs Deal with BioCat
  • Calcium Homeostasis and the Roles of PTH and Calcitonin Peptides
  • The AEgis Technologies Group Announces the Release of acslXtreme Version 2 3
  • NARVALUS Srl IS PLEASED TO ANNOUNCE THE LAUNCH OF THE `T2 TARGET TRANSFECTOR`
  • Swiss venture capitalists explore bionics industry
  • Delivery improvements of the AMD-drug Lucentis on the way
  • GENFIT INITATES PHASE I CLINICAL TRIALS OF GFT505, A MULTIMODAL MOLECULE DEDICATED TO THE PREVENTION AND TREATMENT OF SEVERAL RISK FACTORS OF CARDIOMETABOLIC DISEASE
  • AnaSpec Synthesizes MOG Peptides for MS Research
  • AnaSpec Introduces HTS-Optimized EnzoLyte Caspase Assay Kits
  • Biologics define new standard of therapy in psoriasis
  • AnaSpec Introduces Extensive Line of Caspase Substrates and Inhibitors
  • PREMIER Biosoft Releases Version 6 of Beacon Designer with Support for MethyLight assays
  • China Gets A Spurt Of New Energy
  • Dr Rich Meyer Joins AnaSpec to Lead Detection Reagents Division - Strengthens AnaSpec`s Product Applications Expertise
  • Biopharmaceuticals - A Jewel In The Crown
  • The Crowded Field of VEGF and VEGF-R Targeting Drugs
  • AnaSpec Presents One of the World`s Most Comprehensive Collections of Amyloid Peptides
  • AnaSpec Offers Vital Stains for Amyloid Imaging
  • Potentia Pharmaceuticals Licenses Complement Inhibitor from the University of Pennsylvania
  • AnaSpec Releases 2006-2008 Peptides Catalog
  • AnaSpec Introduces New Line of Secretase Research Solutions
  • A Full Pipeline of Follow-on TNF-Antagonists
  • Genomics Creates Opportunities in Drug Discovery Market
  • HCV Proteases - Wild-Type and Mutated
  • Bio Balance`s Website for Receptor Activation
  • Biotech, Drug Actives, Pharmaceuticals Knowledge Center
  • Biogenerics and new technologies compete with 1st generation major protein products
  • Imminent launches of new EPO products and consolidation of the biogenerics field
  • Localized delivery of PDE-4 inhibitors to open the therapeutic window
  • Licensing Agreement signed between HyperOmics Farma Inc and the Biotechnology Research Institute (NRC)
  • Technical and RandD Investments Reinforce Fortitech Europe`s Growth Objectives
  • The next generation of interferons needs improvement in efficacy and safety
  • Indian Biotech Industry Successful IT cousin
  • LC Sciences Keeps Pace with Sanger miRBase microRNA Sequence Updates
  • RNA interference (RNAi) is coming of age as a therapeutic modality
  • RNCOS Research The Budding India`s Biotech Hub Hyderabad
  • Mondial Translations and Interpreting Launches Referral Program
  • RNCOS Research - The Budding India`s Biotech Hub Hyderabad
  • GENFIT initiates Phase II clinical trials with GFT14
  • Biotechnology Investor Portal, Adds To Online Content
  • RNCOS Research - Indian Biotech Industry Successful IT cousin
  • HEALTHCARE ROYALTY FREE IMAGES AVAILABLE `Royalty Free Medical` Image Collection Available at cmsp com
  • Gentris Announces UGT1A1 Sub-Licensing Agreement
  • RNCOS Research India`s Desire - World`s Future Source for Biotech Appetite
  • Biomaxx Systems Inc joins European Federation of Biotechnology
  • RNCOS Research - India Biotech Disappointed- Not Enough Tax Incentives
  • RNCOS Research - India`s Desire - World`s Future Source for Biotech Appetite
  • Gentris Corporation Introduces Human Genomic DNA Reference Controls for CYP2D6 Gene
  • SciMercor Launches Health Science Equipment and Supplies Auction Site
  • Global Demand Supports Development of Avian Flu Treatments and Antiviral Drugs
  • Zangani Investor Community Announces Interview with ViRexx Medical Corporation President Marc Canton
  • Animal cloning coming soon
  • Biophan and Siemens AG Announce a Declaration of Intent for Strategic Collaboration on Advanced Interventional MRI Technology
  • Bio3 Research and Daxley Group Enter into License Agreement for Biocysan in End-Stage Renal Disease
  • Bio3 Research and Daxley Group Enter into License Agreement for Biocysan in End-Stage Renal Disease
  • Bio Balance`s Most Informative Website for Receptor Activation
  • On-line Messung von Produkteigenschaften und suspendierten Feststoffen - Messung der Produkt-Trennung
  • On-line measurement of product properties and suspended solids - measurement of the product separation
  • The irresistible sirene`s chant of needle-free insulins
  • Antibodies are the first wave of IGF-1R antagonists for cancer therapy
  • Lokmangal Biofertilizers
  • Cornerstone BioPharma, Inc and ASCEND Therapeutics Sign Co-Promotion Agreement
  • Amptronix Inc Debuts its Biometric Product Line
  • Dawn has broken for obesity treatment with cannabinoid receptor (CB1) antagonists
  • TOP 20 Biologics now with sales of US$ 37;7 bln in 2005
  • Professor Marco Bianchi and Creabilis Therapeutics announce the creation of HMGBiotech Srl
  • wwwtransadvanciscom is in and starts its operations
  • Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes
  • BioAxxis(R) Brand Continues Expansion for Axxis Biometrics
  • Emerging diabetes drugs in early development
  • CAS Announces New Featured Company Bridgetech Holdings International Inc
  • High interest in inhibitors of the novel target sodium-dependent glucose (co-) transporter (SGLT) for therapy of type 2 diabetes
  • Tight race to be the first in a new class of dipeptidyl peptidase IV (DPP-IV) inhibitors for the oral treatment of type 2 diabetes
  • Bioluminescence Detection Program by AgroMicron
  • Gentris Announces Promotion and Strategic New Hire
  • Gentris Joins Personalized Medicine Coalition
  • Bio3 Research and Creabilis Therapeutics Sign Research Agreements with Cephalon, Inc
  • Cardiovascular safety determines the direction of PPAR agonist R and D
  • Acrongenomics, Inc. Retains KGMC Group, LLC
  • Competition is needed in the follicle stimulating hormone market
  • Thrombolytic therapy needs innovation
  • New Generation Drug Discovery Software Enters Market
  • A biogeneric company leads the field of next generation human growth hormone (hGH)
  • Too many companies with biogeneric G-CSF products compete for a small market
  • Gentris Corporation Announces Live Webcast
  • SiliconValleyNano.com Nanotech Website Chooses Phaze-9 to Promote Awareness of the Industry
  • CDC and FDA to Discuss Vaccine Stockpiles and Pandemic Influenza Preparedness at Annual Vaccines Conference
  • Scientists Come Together to Discover Possible Cures for Neurodegenerative Diseases
  • New RSS Feeds Feature from BiotechConnection.com
  • RealEngineer.com appoints Mark Singh as New Senior Technical Editor
  • MorphoSys Reports Six Months 2005 Results
  • High-Resolution Brain Atlases in CyberSpace
  • Covance to Present at the FBR 9th Annual Growth Investor Conference
  • Covance Files Lawsuit Against PETA and Its Infiltrator
  • Enzyme Patents RSS Feed
  • ‘Consumable’ Software License Hits the Bioinformatics Street
  • Chimeracom Receives Patent for Heretofore Unknown Family of Analgesic Drugs
  • MD Biosciences and Becton Dickinson sign Agreement For the Distribution of Streptococcus Cell Wall Extract, PG-PS
  • Open Source Expert Joins BioAnalyte
  • Food supplements for a hungry market
  • C. Thomas McMillen Joins the Board of Advisors of BioDefence Corporation
  • SUPPLY NEW BIO-CHEM PHARMACEUTICAL PRODUCTS
  • Reagents-and-Buffers.com (Boston Bioproducts Inc) successfully climbs the ladder in Research Industry

    • Archived Biotech News: 1 - 2 - 3
    Biotech Blog: EPRBiotechNews.com